As a Nurse Practitioner for Neuroblastoma Developmental Therapeutics, my role is to coordinate care for children with recurrent/refractory neuroblastoma. I provide consultations to physicians, nurses and families in order to meet the complex needs of both hospitalized and ambulatory patients with neuroblastoma. I manage the care of patients on investigational trials both while here in Philadelphia and when they travel back to their home institutions in order to provide them with seamless, comprehensive care.
I especially enjoy the close bonds that I am able to develop with patients and families as I help them to navigate their journey through the cancer experience.
Over the 16 years that I have worked in pediatric oncology, I have learned to never let anything surprise me. Children have an amazing way of enjoying life even when dealing with a life-threatening illness. I am humbled by all that they have taught me and continue to teach me every day.
I have presented posters and lectures that focus on all aspects of neuroblastoma, from diagnosis through recurrence and investigational therapies. My research interests lie in neuroblastoma and the investigational treatment options available to this population of patients.
2002, Certified Pediatric Oncology Nurse of the Year
Association of Pediatric Hematology/Oncology Nurses
Oncology Nurses Society
Children's Oncology Group Nursing Discipline
2010-present, Journal of Pediatric Oncology Nursing Continuing Education Committee
Scavuzzo J, Gamba N. Bridging the gap: the virtual chemotherapy unit. J Pediatr Oncol Nurs. 2004 Jan;21(1):27-32. Cited in PubMed: PMID 15058404. Read the abstract
Targeted Radiotherapy for Neuroblastoma – presented at the Advances in Neuroblastoma Treatment Conference in Toronto, Canada (6/18/12)
Targeted therapy for Neuroblastoma – focused on new pharmacologic agents being used for neuroblastoma treatment – presented at The Association of Pediatric Hematology/Oncology Nurses Annual Conference (10/15/12)
Saggio J, Baniewicz D. Immunotherapy for neuroblastoma: how did we get here? Why are we doing it? What's on the horizon? [oral presentation]. The Association of Pediatric Hematology/Oncology Nurses 35th Annual Conference; 2011 Sep 8-10; Anaheim, CA.
Saggio J. A novel approach for treating adolescents and young adults with recurrent high risk neuroblastoma: monthly low dose I131 -metaiodobenzylguanidine [poster presentation]. The Children's Oncology Group Nursing Conference; 2009 Apr 1-5; Atlanta, GA.
Saggio J. Sharing expertise: the role of nurses at the Children's Hospital of Philadelphia in assisting the Children's Hospital of Boston as they develop a program for I131 -metaiodobenzylguanidine therapy [poster presentation]. The Association of Pediatric Hematology/Oncology Nurses; 2008 Sep; Albuquerque, NM.
Saggio J. Relapsed high risk neuroblastoma -- what's the next step? [oral presentation]. The Association of Pediatric Hematology/Oncology Nurses; 2008 Sep; Albuquerque, NM.
Saggio J. Inpatient oncology nurse practitioner comprehensive care model that provides continuity of care as well as education for patients, families and nurses [poster presentation]. The Association of Pediatric Hematology/Oncology Nurses; 2005 Sep; Kansas City, MO.
Saggio J. The permanent inpatient nurse practitioner role in pediatric oncology ensuring clinical support for patients, families and nurses involved in clinical trials [poster presentation]. Children's Oncology Group Nursing Conference; 2005 Mar 29-30; Los Angeles, CA.« Back to Previous Page